SBIR/STTR Research Award
Microport A Minimally Invasive Intraperitoneal Catheter Replacement Port
Award amount
$224,320Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PhysioLogic Devices, Inc.
- Proposal award date
- 2017-06-01
- Contract end date
- 2019-03-31
- UEI
- Not reported
- Solicitation number
- PA16-302
- Topic code
- NIDDK
Research abstract
Project Summary
The clinical advantages of intraperitoneal IP insulin delivery have been established in multiple studies
These advantages include reduction in blood glucose swings reduced frequency of hypoglycemia and
ease of control They are a result of rapid first pass delivery of insulin to the liver rapid clearance of
plasma insulin and normalization of the portal to peripheral insulin gradient
This effort addresses a key component of the long term objective to develop a fully implanted platform
comprising a small pump stable concentrated insulin analog a long life intraperitoneal sensor and
closed loop algorithm This platform is important to public health in that is provides a cost effective
diabetes management tool to the wide diabetic population which offers superior blood glucose control
and reduction in diabetes complications costs and overall health burden
An enabling and necessary component of an IP insulin delivery system is the ability to safely and
efficiently maintain the implanted portions of the system including insulin delivery catheters and glucose
sensors The overall aim of this effort is to develop a fully implanted catheter replacement port as a
component of an implanted pump system The replacement port will provide fluid connection to the
intraperitoneal insulin delivery catheter and electrical connections to the glucose sensors and enable a
safe brief procedure using only a small incision and trocar cannula access to remove and replace the
catheter and sensors
The effort comprises three specific aims Specific Aim includes the manufacture of prototypes and
bench testing Test parameters include reliable connection of the fluid path including absence of leakage
or obstruction to fluid flow resistance of the conductors isolation between distinct conductors isolation
of conductors from the surrounding medium and leakage currents In SA we will verify that a
replacement port in conjunction with an established catheter entry site through the rectus abdominis
muscle is a practical fibrous tissue structure for removing and replacing a catheter In three dogs four
mock catheter replacement ports each will be implanted on the anterior abdominal wall with the
associated catheter extending into the intraperitoneal space total One replacement port will include
a catheter around which a track may be established and two catheter replacement ports will include
experimental catheter guide tubes which penetrate through the abdominal wall The fourth replacement
port will be placed just beneath the anterior rectus sheath in order to simulate a similar necessary
placement in a thin human patient with minimal SQ fat After days implanted the dogs will undergo
removal of the mock catheter replacement ports and replacement of these with new mechanically
functional replacement ports These will then have their associated catheters removed and replaced
transcutaneously using a proprietary exchange catheter to simulate the process in a human Histologic
examination will be performed on the explanted catheters and replacement ports
In SA we will verify the catheter replacement port implant procedure and the catheter replacement
procedure for safety simplicity efficiency and suitability for general surgical suitability using a small
incision and trocar cannula access Using the three dogs from SA at the time of explant of the original
four devices per dog we will implant one replacement port and catheter in a new site in each dog We
seek to confirm that the procedure is minimally invasive brief and attractive to physicians as a simple
procedure Narrative
It is a very difficult daily challenge for diabetics to control their blood sugar and this can lead to many
problems It has been shown that blood sugar control is greatly improved by delivering insulin into the
abdomen known as the intraperitoneal or IP space where it is quickly taken up by the liver instead of
under the skin with needles In this work we will develop a device and procedure which allows safe and
efficient surgical maintenance of a system for delivering insulin into the intraperitoneal space
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1b
- Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes
- Novel Over-the-Scope Platform for Control of Variceal Bleeding
- Tolerogenic Nanotherapy to Delay Type I Diabetes
- An intravascular Bioartificial Pancreas (iBAP)